Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Press Release: Terveystalo sells its Riga based subsidiary Ava Clinic

Terveystalo Oyj
Posted on: 02 Aug 18
  On 31 July 2018, Terveystalo Group has entered into an agreement with Eugin Group, Europe's second largest group fully dedicated to human reproduction, whereby Terveystalo sells to Eugin Group the entire operation of Ava Clinic in Riga.
Ava Clinic provides gynecological services, obstetrician services, as well as infertility treatment. In 2017, the company employed an average of 13 employees and the unit's revenue in 2017 was approximately EUR 3 million.
"We continue to focus on our core business in Finland according to our strategy and with this transaction we are able to release capital for the development of our business. The transaction will also contribute to improving Terveystalo Group's solvency," says Terveystalo's CFO Ilkka Laurila.


Terveystalo Plc
 
For more information, please contact: Kati Kaksonen, Director, Investor Relations and Financial Communications Tel. +358 10 345 2034 Kati.kaksonen@terveystalo.com 


Terveystalo in brief
Terveystalo is a listed company on the Helsinki Stock Exchange. Terveystalo is the largest healthcare service company in Finland with net sales and network. The company offers versatile primary and secondary health care services for corporate and private customers and the public sector. The nationwide network covers approximately 180 locations across Finland, complemented by 24/7 digital services.
In 2017, the Company had approximately 1.2 million individual customers and approximately 3.3 million doctor visits. Nearly 9,000 healthcare professionals work in Terveystalo, about half of whom are private practitioners. Terveystalo is a member of Association for Finnish Work. www.terveystalo.com 

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Terveystalo Oyj via GlobeNewswire
HUG#2207400
GlobeNewswire
globenewswire.com

Last updated on: 03/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.